SCHEMBL26110426

SCHEMBL26110426

O=C(Nc1cccc(NC(=O)c2cc3ccccc3s2)c1)c1ccc2c(c1)OCCO2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.66
▸ KMT2A Q03164 5/20 0.66
▸ MEN1 O00255 4/20 0.66
▸ KDM4E B2RXH2 4/20 0.66
▸ POLB P06746 2/20 0.66
▸ NPC1 O15118 9/20 0.62
▸ RAB9A P51151 8/20 0.62
▸ SMN1; SMN2 Q16637 5/20 0.62
▸ MAOB P27338 4/20 0.62
▸ PKM P14618 2/20 0.62
▸ NFKB1 P19838 1/20 0.62
▸ NFKB2 Q00653 1/20 0.62
▸ RELA Q04206 1/20 0.62
▸ TP53 P04637 3/20 0.59
▸ TSHR P16473 1/20 0.59
▸ LMNA P02545 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ HTT P42858 1/20 0.57
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30597718 1.00 MAPT (0.66) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL26535611 0.87 MAOB (0.59) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL26111733 0.87 HSF1 (0.64) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL26535608 0.87 MAOB (0.59) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL30597751 0.87 HSF1 (0.64) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL26136510 0.83 HSF1 (0.60) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL30597799 0.83 HSF1 (0.60) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL25715073 0.83 RAB9A (0.52) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL30464286 0.79 RAB9A (0.53) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL25715808 0.79 RAB9A (0.53) MAPTKMT2AMEN1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028334-A1 N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER WMT AG (DE) 2026-01-29 — — US disclosed
EP-4504723-A1 N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER WMT AG (DE) 2025-02-12 — — EP disclosed
WO-2023194458-A1 N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER WMT AG (DE) 2023-10-12 — — WO disclosed
WO-2023194458-A1 N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER WMT AG (DE) 2023-10-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028334-A1 N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER LDHA, LDHB, SLC6A1 MAPT 3802/4885KMT2A 3028/4885MEN1 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback